[via Business Wire] Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer Date Published: Date of Event: Link: https://www.businesswire.com/news/home/20250909675042/en/Tempus-Announces-New-Study-in-JCO-Precision-Oncology-Validating-PurIST-Algorithm-for-Enhanced-Therapy-Selection-in-Pancreatic-Cancer
